Title: Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients
with treatment-naïve chronic hepatitis B
Version: 2 Date: 07 Feb 2022
Reviewer's report:
Dear Authors
“Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients with
treatment-naïve chronic hepatitis B”.
This is study was to evaluate the antiviral activity and safety of ETV-Generic in comparison to
ETV-Brand in patients with CHB. However, there is a major problem that is difficult to accept
this manuscript.
1. The reader should read the article that is new or interesting, but there is no new or interesting
content in this manuscript.
2. This is a small retrospective study. If you want to confirm your suggestion, you need to do
a prospective study with two groups.
3. It does not fit the format of this journal for tables and figures to enter the middle of the
manuscript.
Title: Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients
with treatment-naïve chronic hepatitis B
Version: 2 Date: 07 Feb 2022
Reviewer's report:
Dear Authors
“Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients with
treatment-naïve chronic hepatitis B”.
This is study was to evaluate the antiviral activity and safety of ETV-Generic in comparison to
ETV-Brand in patients with CHB. However, there is a major problem that is difficult to accept
this manuscript.
1. The reader should read the article that is new or interesting, but there is no new or interesting
content in this manuscript.
2. This is a small retrospective study. If you want to confirm your suggestion, you need to do
a prospective study with two groups.
3. It does not fit the format of this journal for tables and figures to enter the middle of the
manuscript.
Please review this paper.
user
Title: Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients
with treatment-naïve chronic hepatitis B
Version: 2 Date: 07 Feb 2022
Reviewer's report:
Dear Authors
“Analysis of Antiviral Efficacy after Switching from Brand to Generic Entecavir in patients with
treatment-naïve chronic hepatitis B”.
This is study was to evaluate the antiviral activity and safety of ETV-Generic in comparison to
ETV-Brand in patients with CHB. However, there is a major problem that is difficult to accept
this manuscript.
1. The reader should read the article that is new or interesting, but there is no new or interesting
content in this manuscript.
2. This is a small retrospective study. If you want to confirm your suggestion, you need to do
a prospective study with two groups.
3. It does not fit the format of this journal for tables and figures to enter the middle of the
manuscript.
assistant